Rosuvastatin Completed Phase 2 Trials for Hyperlipidemias / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00184951Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
NCT00296400Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease